FOLD logo

Amicus Therapeutics, Inc. (FOLD) Retained Earnings

Annual Retained Earnings:

-$2.74B-$56.11M(-2.09%)
December 31, 2024

Summary

  • As of today, FOLD annual retained earnings is -$2.74 billion, with the most recent change of -$56.11 million (-2.09%) on December 31, 2024.
  • During the last 3 years, FOLD annual retained earnings has fallen by -$444.26 million (-19.35%).
  • FOLD annual retained earnings is now -32126.04% below its all-time high of -$8.50 million, reached on December 31, 2003.

Performance

FOLD Retained Earnings Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherFOLDbalance sheet metrics

Quarterly Retained Earnings:

-$2.79B-$24.42M(-0.88%)
June 30, 2025

Summary

  • As of today, FOLD quarterly retained earnings is -$2.79 billion, with the most recent change of -$24.42 million (-0.88%) on June 30, 2025.
  • Over the past year, FOLD quarterly retained earnings has dropped by -$38.10 million (-1.39%).
  • FOLD quarterly retained earnings is now -7365.45% below its all-time high of -$37.32 million, reached on December 31, 2005.

Performance

FOLD Quarterly Retained Earnings Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherFOLDbalance sheet metrics

Retained Earnings Formula

Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid

FOLD Retained Earnings Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1Y1 Year-2.1%-1.4%
3Y3 Years-19.4%-14.0%
5Y5 Years-54.9%-45.9%

FOLD Retained Earnings Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs Low
3Y3-Year-19.4%at low-12.5%at low
5Y5-Year-54.9%at low-41.1%at low
All-TimeAll-Time>-9999.0%at low-7365.4%at low

FOLD Retained Earnings History

DateAnnualQuarterly
Jun 2025
-
-$2.79B(-0.9%)
Mar 2025
-
-$2.76B(-0.8%)
Dec 2024
-$2.74B(-2.1%)
-$2.74B(+0.5%)
Sep 2024
-
-$2.75B(-0.2%)
Jun 2024
-
-$2.75B(-0.6%)
Mar 2024
-
-$2.73B(-1.8%)
Dec 2023
-$2.68B(-6.0%)
-$2.68B(-1.3%)
Sep 2023
-
-$2.65B(-0.8%)
Jun 2023
-
-$2.63B(-1.7%)
Mar 2023
-
-$2.59B(-2.1%)
Dec 2022
-$2.53B(-10.3%)
-$2.53B(-2.3%)
Sep 2022
-
-$2.48B(-1.4%)
Jun 2022
-
-$2.44B(-2.6%)
Mar 2022
-
-$2.38B(-3.7%)
Dec 2021
-$2.30B(-12.2%)
-$2.30B(-3.8%)
Sep 2021
-
-$2.21B(-2.3%)
Jun 2021
-
-$2.16B(-2.4%)
Mar 2021
-
-$2.11B(-3.2%)
Dec 2020
-$2.05B(-15.7%)
-$2.05B(-3.6%)
Sep 2020
-
-$1.97B(-3.4%)
Jun 2020
-
-$1.91B(-2.8%)
Mar 2020
-
-$1.86B(-5.0%)
Dec 2019
-$1.77B(-25.2%)
-$1.77B(-5.3%)
Sep 2019
-
-$1.68B(-3.8%)
Jun 2019
-
-$1.62B(-5.5%)
Mar 2019
-
-$1.53B(-8.5%)
Dec 2018
-$1.41B(-32.8%)
-$1.41B(-5.9%)
Sep 2018
-
-$1.33B(-13.5%)
Jun 2018
-
-$1.17B(-5.6%)
Mar 2018
-
-$1.11B(-4.7%)
Dec 2017
-$1.06B(-36.4%)
-$1.06B(-7.0%)
Sep 2017
-
-$994.40M(-12.6%)
Jun 2017
-
-$882.74M(-5.8%)
Mar 2017
-
-$834.60M(-7.1%)
Dec 2016
-$779.61M(-34.5%)
-$779.61M(-8.1%)
Sep 2016
-
-$720.96M(-6.9%)
Jun 2016
-
-$674.31M(-8.2%)
Mar 2016
-
-$623.26M(-7.5%)
Dec 2015
-$579.57M
-$579.57M(-8.0%)
DateAnnualQuarterly
Sep 2015
-
-$536.67M(-7.6%)
Jun 2015
-
-$498.87M(-5.8%)
Mar 2015
-
-$471.74M(-5.4%)
Dec 2014
-$447.45M(-18.2%)
-$447.45M(-5.0%)
Sep 2014
-
-$426.23M(-4.2%)
Jun 2014
-
-$409.08M(-3.7%)
Mar 2014
-
-$394.46M(-4.2%)
Dec 2013
-$378.52M(-18.7%)
-$378.52M(-3.3%)
Sep 2013
-
-$366.29M(-4.1%)
Jun 2013
-
-$351.70M(-4.6%)
Mar 2013
-
-$336.35M(-5.5%)
Dec 2012
-$318.89M(-18.1%)
-$318.89M(-3.2%)
Sep 2012
-
-$308.87M(-5.6%)
Jun 2012
-
-$292.58M(-3.3%)
Mar 2012
-
-$283.24M(-4.9%)
Dec 2011
-$270.10M(-19.7%)
-$270.10M(-3.3%)
Sep 2011
-
-$261.44M(-3.9%)
Jun 2011
-
-$251.68M(-5.3%)
Mar 2011
-
-$239.04M(-5.9%)
Dec 2010
-$225.69M(-32.2%)
-$225.69M(-7.2%)
Sep 2010
-
-$210.60M(-7.9%)
Jun 2010
-
-$195.25M(-6.2%)
Mar 2010
-
-$183.93M(-7.7%)
Dec 2009
-$170.76M(-4.0%)
-$170.76M(+16.2%)
Sep 2009
-
-$203.71M(-7.1%)
Jun 2009
-
-$190.28M(-7.7%)
Mar 2009
-
-$176.66M(-7.6%)
Dec 2008
-$164.19M(-31.5%)
-$164.19M(-9.4%)
Sep 2008
-
-$150.04M(-5.8%)
Jun 2008
-
-$141.86M(-7.0%)
Mar 2008
-
-$132.56M(-6.2%)
Dec 2007
-$124.83M(-34.7%)
-$124.83M(-10.4%)
Sep 2007
-
-$113.06M(-10.0%)
Jun 2007
-
-$102.76M(-10.1%)
Mar 2007
-
-$93.36M(-0.7%)
Dec 2006
-$92.69M(-434.3%)
-$92.69M(-148.3%)
Dec 2005
-
-$37.32M
Dec 2004
-$17.35M(-104.0%)
-
Dec 2003
-$8.50M
-

FAQ

  • What is Amicus Therapeutics, Inc. annual retained earnings?
  • What is the all-time high annual retained earnings for Amicus Therapeutics, Inc.?
  • What is Amicus Therapeutics, Inc. annual retained earnings year-on-year change?
  • What is Amicus Therapeutics, Inc. quarterly retained earnings?
  • What is the all-time high quarterly retained earnings for Amicus Therapeutics, Inc.?
  • What is Amicus Therapeutics, Inc. quarterly retained earnings year-on-year change?

What is Amicus Therapeutics, Inc. annual retained earnings?

The current annual retained earnings of FOLD is -$2.74B

What is the all-time high annual retained earnings for Amicus Therapeutics, Inc.?

Amicus Therapeutics, Inc. all-time high annual retained earnings is -$8.50M

What is Amicus Therapeutics, Inc. annual retained earnings year-on-year change?

Over the past year, FOLD annual retained earnings has changed by -$56.11M (-2.09%)

What is Amicus Therapeutics, Inc. quarterly retained earnings?

The current quarterly retained earnings of FOLD is -$2.79B

What is the all-time high quarterly retained earnings for Amicus Therapeutics, Inc.?

Amicus Therapeutics, Inc. all-time high quarterly retained earnings is -$37.32M

What is Amicus Therapeutics, Inc. quarterly retained earnings year-on-year change?

Over the past year, FOLD quarterly retained earnings has changed by -$38.10M (-1.39%)
On this page